Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.183 | -50.9749303621 | 0.359 | 0.3833 | 0.141 | 8819705 | 0.27922472 | CS |
4 | -0.2198 | -55.533097524 | 0.3958 | 0.4202 | 0.141 | 2402557 | 0.28203395 | CS |
12 | -0.13 | -42.4836601307 | 0.306 | 0.6559 | 0.141 | 7190483 | 0.52765274 | CS |
26 | -5.314 | -96.7941712204 | 5.49 | 5.5 | 0.141 | 3686138 | 0.60142751 | CS |
52 | -15.8224 | -98.899889989 | 15.9984 | 21.56 | 0.141 | 2097860 | 1.69763018 | CS |
156 | -748.264 | -99.9764844209 | 748.44 | 971.5156 | 0.141 | 1120404 | 196.02515321 | CS |
260 | -29.304 | -99.4029850746 | 29.48 | 2640 | 0.141 | 869874 | 272.64106192 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.